You are currently viewing a new version of our website. To view the old version click .

Most Recent

  • Review
  • Open Access
197 Views
23 Pages

Targeting the Cellular Prion Protein as a Biomarker for Stem Cells, Cancer, and Regeneration

  • Niccolò Candelise,
  • Nicola Salvatore Orefice,
  • Elisabetta Mantuano and
  • Stefano Martellucci

24 December 2025

The cellular prion protein (PrPC) displays a functional repertoire that extends well beyond its classical link to transmissible spongiform encephalopathies. Abundant in the nervous system and localized within lipid raft microdomains, PrPC has emerged...

  • Article
  • Open Access
232 Views
14 Pages

Automated Scale-Down Development and Optimization of [68Ga]Ga-DOTA-EMP-100 for Non-Invasive PET Imaging and Targeted Radioligand Therapy of c-MET Overactivation in Cancer

  • Silvia Migliari,
  • Anna Gagliardi,
  • Alessandra Guercio,
  • Maura Scarlattei,
  • Giorgio Baldari,
  • Alex Gibson,
  • Christophe Portal and
  • Livia Ruffini

17 December 2025

Background/Objectives: Overactivation of the HGF/c-MET pathway is implicated in various cancers, making its inhibition a promising therapeutic strategy. While several MET-targeting agents are currently approved or in advanced clinical development, pa...

  • Article
  • Open Access
835 Views
12 Pages

Risk of Developing Clostridioides Difficile Infection with the Use of Proton Pump Inhibitors in Patients with Inflammatory Bowel Disease

  • Mustafa Gandhi,
  • Harleen Kaur Chela,
  • Maxwell A. Barffour,
  • Emily Bosak,
  • Emily Reznicek,
  • Kevin Luton,
  • Matthew Bechtold and
  • Yezaz A. Ghouri

1 December 2025

Introduction: Patients with inflammatory bowel disease (IBD) have an increased risk of Clostridioides difficile infection (CDI). While antibiotic exposure has been considered the most prominent risk factor for CDI, proton pump inhibitor (PPI) use is...

  • Review
  • Open Access
855 Views
15 Pages

Mesenchymal Stem Cells and Their Derivatives: Old Problems and New Possibilities in Regenerative Medicine for Neurological Diseases

  • Elvira Akhmetzyanova,
  • Ilya Shulman,
  • Taisiya Fakhrutdinova,
  • Albert Rizvanov and
  • Yana Mukhamedshina

28 November 2025

Mesenchymal stem cells are multipotent stromal cells with immunomodulatory, anti-inflammatory, and trophic properties that support tissue repair and regeneration. Increasing evidence suggests that their therapeutic effects are primarily mediated by p...

  • Review
  • Open Access
1,399 Views
21 Pages

10 November 2025

Lyophilization (freeze-drying) has become a cornerstone pharmaceutical technology for stabilizing biopharmaceuticals, overcoming the inherent instability of biologics, vaccines, and complex drug formulations in aqueous environments. The appropriate l...

  • Article
  • Open Access
560 Views
20 Pages

3 November 2025

Background: Various thiolactones are known as biologically active compounds, capable of stimulating the development of several human diseases and quorum sensing of Gram–positive bacteria. The enzymatic hydrolysis of thiolactones represents a pr...

  • Article
  • Open Access
1,864 Views
11 Pages

22 October 2025

Background/Objectives: Omalizumab is a monoclonal anti-IgE antibody approved for the treatment of chronic urticaria. There are no established or validated prognostic markers currently available to identify likely responders. The aim of this study was...

  • Article
  • Open Access
920 Views
25 Pages

13 October 2025

Background/Objectives: Obesity increases reactive oxygen species (ROS), thereby triggering oxidative stress. Coriander seeds contain polyphenolic compounds that act as natural antioxidants to reduce oxidative stress. Coriander seed ethanolic extract...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Biologics - ISSN 2673-8449